ici 164384 has been researched along with 8-bromo cyclic adenosine monophosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronica, SM; Katzenellenbogen, BS | 1 |
| Chalbos, D; Galtier, F; Philips, A; Rochefort, H | 1 |
2 other study(ies) available for ici 164384 and 8-bromo cyclic adenosine monophosphate
| Article | Year |
|---|---|
Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Cyclic AMP; Estradiol; Estrogen Antagonists; Female; Insulin-Like Growth Factor I; Isoquinolines; Phosphorylation; Polyunsaturated Alkamides; Protein Kinase Inhibitors; Rats; Receptors, Estrogen; TATA Box; Transcription, Genetic; Transfection; Uterus | 1993 |
Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Breast Neoplasms; Cathepsin D; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Growth Substances; Humans; Insulin-Like Growth Factor I; Neoplasm Proteins; Polyunsaturated Alkamides; Proteins; RNA, Messenger; Tamoxifen; Tetradecanoylphorbol Acetate; Transcription, Genetic; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1993 |